Cogent Biosciences, Inc. (COGT) Net margin 2018–2021
Cogent Biosciences, Inc. (COGT) net profit margin by fiscal year — reported net income divided by reported revenue.
-918.2%FY2021 · since FY2018: -413.1% → -918.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -918.2% | -585.7 pp |
| FY2020 | -332.5% | -5.5 pp |
| FY2019 | -327.0% | +86.0 pp |
| FY2018 | -413.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More COGT financial trends
COGT RevenueCOGT Net incomeCOGT Gross profitCOGT Gross marginCOGT Operating incomeCOGT Operating marginCOGT Operating cash flowCOGT Free cash flowCOGT Capital expendituresCOGT Return on equityCOGT Stock buybacksCOGT Dividends paidCOGT Total assetsCOGT Total liabilitiesCOGT Shareholders’ equityCOGT overview →